Please wait
0001628171424B5EX-FILING FEESPre-funded warrants to purchase Common Stock, $0.0001 par value per share 0001628171 2024-12-04 2024-12-04 0001628171 1 2024-12-04 2024-12-04 0001628171 2 2024-12-04 2024-12-04 iso4217:USD xbrli:pure
Exhibit 107
Calculation of Filing Fee Tables
424(b)(5)
(Form Type)
Revolution Medicines, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
 
                 
    
Security
Type
 
Security
Class
Title
 
Fee
Calculation
or Carry
Forward
Rule
 
Amount
Registered
 
Proposed
Maximum
Offering
Price Per
Unit
 
Maximum
Aggregate
Offering
Price (1)
 
Fee
Rate
 
Amount of
Registration
Fee (1)
 
Newly Registered Securities
                 
Fees to Be
Paid
  Equity   Common Stock, $0.0001 par value per share   Rule 457(r)   18,750,005 (2)   $46.00   $862,500,230   $0.0001531   $132,049
                 
Fees to Be
Paid
  Equity  
Pre-funded
warrants to purchase Common Stock, $0.0001 par value per share
  Rule 457(r)   2,173,917   $46.00 (3)   $ (3)   $0.0001531   $
                 
Fees
Previously
Paid
  N/A   N/A   N/A   N/A   N/A   N/A     N/A
 
Carry Forward Securities
                 
Carry Forward
Securities
  N/A   N/A   N/A   N/A     N/A      
           
   
Total Offering Amounts 
    $862,500,230     $132,049 (1)
           
   
Total Fees Previously Paid 
        $
           
   
Total Fee Offsets 
        $
           
   
Net Fee Due 
              $132,049
 
(1)
In accordance with Rules 456(b) and 457(r) under the Securities Act of 1933, as amended, the registrant initially deferred payment of all of the registration fees for the Registration Statement on Form
S-3
(Registration
No. 333-277640),
filed on March 4, 2024.
(2)
Includes 2,445,652 shares of the registrant’s common stock, $0.0001 par value per share (the “Common Stock”), that the underwriters have an option to purchase and 2,173,917 shares of Common Stock that are issuable upon the exercise of
pre-funded
warrants referenced below.
(3)
Represents the sum of the
pre-funded
warrants sales price of $45.9999 per
pre-funded
warrant and the exercise price of $0.0001 per share of Common Stock issuable pursuant to the
pre-funded
warrants. Pursuant to Securities and Exchange Commission staff interpretation, the entire fee is allocated to the Common Stock underlying the
pre-funded
warrants.